Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US7170811035
Ticker PFE
Company PFIZER
Currency $
Price
Aware Investor Index (AII) 4.8459
Recommendation BUY
P/E 22.69
ROE 16.29 %
Capitalization 263,644,160,000 $
Dividend Yield 2.94 %
P/S 5.02
AII Position 129
P/E Position 311
ROE Position 200
Capitalization Position 19
Dividend Yield Position 234
Sales 52,546,000,000 $
10-Year Average Earnings 11,619,600,000 $
Shares Outstanding 6,058,000,000
Equity 71,308,000,000 $
Dividend per Share 1.28 $
Industry Pharmaceutical
Country United States
PFIZER Investor Relations Web Site http://www.pfizer.com/investors/







Sales:

YEAR MONTH AMOUNT
2017 12 52,546,000,000.00 $
2016 12 52,824,000,000.00 $
2015 12 48,851,000,000.00 $
2014 12 49,605,000,000.00 $
2013 12 51,584,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 21,308,000,000.00 $
2016 12 7,215,000,000.00 $
2015 12 6,960,000,000.00 $
2014 12 9,135,000,000.00 $
2013 12 22,003,000,000.00 $
2012 12 14,570,000,000.00 $
2011 12 10,009,000,000.00 $
2010 12 8,257,000,000.00 $
2009 12 8,635,000,000.00 $
2008 12 8,104,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 71,308,000,000.00 $
2016 12 59,544,000,000.00 $
2015 12 64,998,000,000.00 $
2014 12 71,622,000,000.00 $
2013 12 76,620,000,000.00 $
2012 12 81,678,000,000.00 $
2011 12 82,621,000,000.00 $
2010 12 88,265,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 6,058,000,000
2016 12 6,159,000,000
2015 12 6,257,000,000
2014 12 6,424,000,000
2013 12 6,895,000,000
2012 12 7,508,000,000
2011 12 7,870,000,000
2010 12 8,074,000,000
2009 12 7,045,000,000

 












Bloomberg News for PFIZER:



Google News for PFIZER:

Zacks.com - 2 days ago
Pfizer (PFE) Stock Moves -0.38%: What You Should Know
Investors will be hoping for strength from PFE as it approaches its next earnings release, which is expected to be January 29, 2019.
Motley Fool - 3 days ago
Better Buy: Amgen Inc. vs. Pfizer Inc.
Amgen Inc. (NASDAQ:AMGN) and Pfizer Inc. (NYSE:PFE) were once partners. The two companies jointly marketed autoimmune-disease drug ...
Yahoo Finance - 6 Nov 2018
Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know
Pfizer (PFE) closed the most recent trading day at $42.99, moving -1.22% from the previous trading session. This change lagged the S&P 500's ...
CNBC - 1 Nov 2018
Pfizer downgraded by BMO: 'Significant headwinds' will cap the ...
BMO Capital Markets downgraded Pfizer to market perform and told ... "However, these seem mostly reflected in the stock, and near-term ...
Investopedia
Pfizer loses blockbuster drug patent fight in UK Supreme Court
LONDON (Reuters) - Pfizer <PFE.N> lost the final round in a long-running patent battle in Britain on Wednesday after the country's highest court ...
euronews - 11 hours ago
Citigroup Boosts Pfizer (PFE) Price Target to $37.00
Pfizer (NYSE:PFE) had its target price boosted by investment analysts at Citigroup from $34.00 to $37.00 in a research note issued to investors ...
Seeking Alpha
Pfizer $PFE Technical Update
The Pfizer (NYSE: PFE) update and the technical summary table below can help you manage risk and optimize returns. We have day, swing, ...
Endpoints News
Cancer Research Highlight: Pfizer Looks To Re-Enter The ALK Race
Pfizer (PFE) was a pioneer in therapy for ALK-positive NSCLC, since they developed the first approved therapy for the disease, a tyrosine ...
Yahoo Finance UK
Pfizer (PFE) Q3 2018 Results - Earnings Call Transcript
Pfizer Inc. (NYSE:PFE) Q3 2018 Earnings Call October 30, 2018 10:00 AM ET. Executives. Charles E. Triano - Pfizer Inc. Ian C. Read - Pfizer ...
Fairfield Current - 6 hours ago
Pfizer (PFE) Stock Moves -0.29%: What You Should Know
Pfizer (PFE) closed the most recent trading day at $44.37, moving -0.29% from the previous trading session. This move was narrower than the ...


Back